|
Active Immunotheraphy
Cancer researchers have long looked for
innovative approaches that boost the human
immune system's ability to fight disease.
In recent years, both active and passive
immunotherapy have gained recognition as
new tools in the fight against cancer.
With the advent of monoclonal antibody
drugs, passive immunotherapy has become an
important part of anti-cancer treatment
regimens.
Therion believes, however, that active
immunotherapy, or the stimulation of the
body's innate immune response, holds even
greater promise for cancer treatment.
While antibodies are one element of immune
defense, researchers now recognize
cell-mediated immune responses as critical
for tumor destruction.
|
Click for animated
slide
1
Click for animated slide
2
|
